Menu
Enrolling by invitation NCT06591182

Effects of Social Determinants of Health on IV Iron Treatments

— Observational Social Determinants of Health (SDOH)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Survey using a questionnaire..
Who it may be relevant to
Registry conditions: Social Determinants of Health (SDOH). Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Impacts of Social Determinants of Health for Patients Seeking Intravenous Iron Treatments At a Large Community Hospital Adult Infusion Center

Overview

This study investigates how social determinants of health (SDOH) like income, employment, transportation, food, and housing affect patients' ability to receive IV iron treatments. It aims to understand how these factors influence patients' healthcare behaviors, particularly their attendance at IV iron appointments.

Interventions

  • Other Survey using a questionnaire.
    Observational study, participants are not assigned an intervention as part of the study (Survey using a questionnaire).

Primary outcome measures

  • Association between SDOH and patient compliance [Time frame: Through study completion, an average of 1 year]
Secondary outcome measures (1)
  • Patient Perceptions of IV Iron [Time frame: Through study completion, an average of 1 year]

Eligibility criteria

Inclusion criteria

  • Patients receiving one of the following IV iron products: Ferric Carboxymaltose, Ferric Derisomaltose, Ferumoxytol, Iron Sucrose, or Iron Dextran
  • Patients 18 years of age or older
  • Patients who speak English or Spanish

Exclusion criteria

  • Patients receiving an alternative IV iron product: Sodium ferric gluconate
  • Patients under 18 years of age
  • Patients who do not speak English or Spanish

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • St. Josephs Hospital Adult Infusion Center — Tampa

Identifiers

NCT: NCT06591182 · 2024.001-BSJH · NIS-ISS-37 SDoH

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗